Insider · CIK 0002035474
Pascal Bamford
Files at AKYA (Akoya Biosciences, Inc.). First filing -, latest -.
Pascal Bamford files SEC Form 4 as officer at AKYA (Akoya Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Pascal Bamford has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Common Stock | -9,488 | - | - | 196,250 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Common Stock | -196,250 | - | - | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Employee Stock Option (Right to Buy)derivative | -150,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Employee Stock Option (Right to Buy)derivative | -25,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Employee Stock Option (Right to Buy)derivative | -15,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Employee Stock Option (Right to Buy)derivative | -50,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jun 1, 2025 | AKYA Akoya Biosciences, Inc. | FTax withholding Common Stock | -670 | $1.25 | $838 | 205,738 | Jun 2, 2025 |
| Mar 1, 2025 | AKYA Akoya Biosciences, Inc. | FTax withholding Common Stock | -1,283 | $1.63 | $2,091 | 208,975 | Mar 4, 2025 |
| Mar 1, 2025 | AKYA Akoya Biosciences, Inc. | FTax withholding Common Stock | -2,567 | $1.63 | $4,184 | 206,408 | Mar 4, 2025 |
| Nov 19, 2024 | AKYA Akoya Biosciences, Inc. | AGrant or award Common Stock | +87,500 | $0.00 | $0 | 210,258 | Nov 21, 2024 |
Questions about Pascal Bamford
Answered from the filings on this page, as of the latest one.
Is Pascal Bamford buying or selling?
Pascal Bamford has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Pascal Bamford's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Pascal Bamford has 0.
Where does Pascal Bamford file Form 4?
Pascal Bamford has filed Form 4 at AKYA (Akoya Biosciences, Inc.) as Chief Clinical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.